| 1 |
32173650 | T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer. | 2020 Jul 1 |
1 |
| 2 |
30108864 | Characterization and lymphocyte proliferation activity of an oligosaccharide degraded from Astragalus polysaccharide. | 2017 Jul 1 |
1 |
| 3 |
22754788 | Chemoimmunotherapy as long-term maintenance therapy for cancer. | 2012 Jul 1 |
1 |
| 4 |
21702643 | Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lymphoma. | 2011 Nov |
1 |
| 5 |
18316569 | Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation. | 2008 Mar 1 |
1 |
| 6 |
17284714 | Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. | 2007 Feb 7 |
1 |
| 7 |
15989703 | The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma. | 2005 Jun |
2 |
| 8 |
16110137 | Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphoma. | 2005 |
1 |
| 9 |
14595707 | Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience. | 2003 Dec |
1 |
| 10 |
10784622 | Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF. | 2000 May |
1 |
| 11 |
10379842 | A possible role for granulocyte macrophage-colony stimulating factor in modulating teratogen-induced effects. | 1999 |
1 |
| 12 |
10402245 | The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. | 1999 Aug |
1 |
| 13 |
10509151 | Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors. | 1999 Aug |
1 |
| 14 |
9402167 | Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer. | 1997 Oct |
1 |
| 15 |
9446257 | [Low-dose GM-CSF and dose intensity of antineoplastic agents]. | 1997 Sep-Oct |
2 |
| 16 |
8602629 | Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin. | 1996 Apr |
2 |
| 17 |
8630380 | Prospective, randomized trial of 5-fluorouracil, leucovorin, doxorubicin, and cyclophosphamide chemotherapy in combination with the interleukin-3/granulocyte-macrophage colony-stimulating factor (GM-CSF) fusion protein (PIXY321) versus GM-CSF in patients with advanced breast cancer. | 1996 Mar 15 |
2 |
| 18 |
8823488 | Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer. | 1996 |
3 |
| 19 |
8856281 | Treatment of severe leukopenia with RHG-CSF in systemic lupus erythematosus treated with cyclophosphamide. | 1996 |
1 |
| 20 |
8913281 | Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial. | 1996 Oct |
2 |
| 21 |
7533827 | Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. | 1995 Mar |
1 |
| 22 |
7749762 | A phase I and II trial of dose-intensified cyclophosphamide and GM-CSF in pediatric malignant brain tumors. | 1995 May |
2 |
| 23 |
7522393 | The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel Project. | 1994 Oct |
3 |
| 24 |
7989942 | Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma. | 1994 Dec |
1 |
| 25 |
8123484 | A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian cancer. | 1994 Mar |
1 |
| 26 |
8103811 | Peripheral blood stem cells harvested after chemotherapy and GM-CSF for treatment intensification in patients with advanced lymphoproliferative diseases. | 1993 Sep |
1 |
| 27 |
8246030 | Phase I trial of recombinant human granulocyte-macrophage colony-stimulating factor derived from yeast in patients with breast cancer receiving cyclophosphamide, doxorubicin, and fluorouracil. | 1993 Dec |
1 |
| 28 |
8340944 | Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study. | 1993 Aug 18 |
2 |
| 29 |
8349185 | Reduction of plasma fibrinolytic activity following high-dose cyclophosphamide is neutralized in vivo by GM-CSF administration. | 1993 Mar-Apr |
1 |
| 30 |
8398836 | Effect of cytotoxic drugs on mature neutrophil function in the presence and absence of granulocyte-macrophage colony-stimulating factor. | 1993 Jun |
1 |
| 31 |
1586713 | Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow. | 1992 May 15 |
1 |
| 32 |
1657333 | In vivo stimulation of myelopoiesis in cyclophosphamide-treated mice by purified human GM-CSF. | 1991 Sep |
3 |
| 33 |
1911464 | Response to high dose cyclophosphamide with GM-CSF in Merkel cell tumor. | 1991 Jul |
1 |
| 34 |
1988077 | A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma. | 1991 Jan 1 |
1 |
| 35 |
2020314 | [The hematopoietic growth factor GM-CSF in chemotherapy for ovarian carcinoma]. | 1991 Mar 9 |
1 |
| 36 |
2185337 | Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. | 1990 May |
1 |
| 37 |
2190885 | High-dose cyclophosphamide in patients with operable breast cancer: recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia. | 1990 Jan-Feb |
1 |
| 38 |
2478216 | Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. | 1989 Nov 1 |
1 |
| 39 |
2570283 | Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. | 1989 Sep 9 |
2 |
| 40 |
3135686 | Granulopoietic effects of colony-stimulating factor obtained from urine of patients with aplastic anemia on normal and cyclophosphamide-treated mice. | 1988 |
1 |
| 41 |
3500779 | Immune response by biological response modifiers. | 1987 |
1 |